Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Management Tracks

Wigerinck to leave Galapagos; plus Kymera, Alladapt, Nurix, Alchemab, Novome and more

June 22, 2021 7:42 PM UTC

Piet Wigerinck will step down this year after serving as CSO for nine years at Galapagos N.V. (Euronext:GLPG; NASDAQ:GLPG), overseeing the Belgian biotech’s programs from the discovery of targets through clinical proof of concept. CMO Walid Abi-Saab, who joined the company in late 2017 to oversee late-stage development, will be responsible for early-stage activities as the company searches for a successor. The announcement follows a series of clinical setbacks for the Belgian biotech. 

Kymera Therapeutics Inc. (NASDAQ:KYMR) hired Elaine Caughey as CBO. Caughey joins the protein degradation company from Cygnal Therapeutics Inc., where she was CBO. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article